What RVL Pharmaceuticals plc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Harsaul Foundation | 10% owner | Oct 20 | Open-market sale · S | −4,758,899 | $0.03 | −$148K | 4,941,101 |
| Altchem Ltd | 10% owner | Oct 20 | Open-market sale · S | −4,758,899 | $0.03 | −$148K | 4,941,101 |
| Harsaul Foundation | 10% owner | Oct 19 | Open-market sale · S | −9,363,760 | $0.05 | −$432K | 9,700,000 |
| Altchem Ltd | 10% owner | Oct 19 | Open-market sale · S | −9,363,760 | $0.05 | −$432K | 9,700,000 |
| Altchem Ltd | 10% owner | Oct 18 | Open-market sale · S | −3,421,537 | $0.06 | −$221K | 19,063,760 |
| Harsaul Foundation | 10% owner | Oct 18 | Open-market sale · S | −3,421,537 | $0.06 | −$221K | 19,063,760 |
| Avista Healthcare Partners GP, Ltd. | 10% owner | Aug 15 | Other Transaction · J | −23,730,864 | — | — | 0 |
| Lask Alisa | Director | Aug 10 | Withheld — tax / exercise cost · F | −12,000 | $0.49 | −$5.88K | 112,557 |
| Lask Alisa | Director | Jul 05 | Grant / award · A | +40,000 | — | — | 124,557 |
| DeBiasi Michael J. | Director | Jul 05 | Grant / award · A | +40,000 | — | — | 40,000 |
| Cowan Gregory L | Director | Jul 05 | Grant / award · A | +40,000 | — | — | 90,055 |
| Schaub James | EVP and COO | May 18 | Withheld — tax / exercise cost · F | −5,577 | $0.87 | −$4.85K | 524,835 |
| Klein Christopher | General Counsel & Secretary | May 18 | Withheld — tax / exercise cost · F | −5,447 | $0.87 | −$4.74K | 180,573 |
| Burgstahler David F | Director | Jan 27 | Other Transaction · J | −1,032,995 | — | — | 0 |
| Avista Capital Partners Iii GP, L.p. | 10% owner | Jan 27 | Other Transaction · J | −1,032,995 | — | — | 0 |
| Venkataraman Sriram | Director | Jan 27 | Other Transaction · J | −1,032,995 | — | — | 0 |
| Schaub James | EVP and COO | Jan 24 | Withheld — tax / exercise cost · F | −9,608 | $1.26 | −$12.1K | 530,412 |
| Klein Christopher | General Counsel & Secretary | Jan 24 | Withheld — tax / exercise cost · F | −9,608 | $1.26 | −$12.1K | 186,020 |
| Lask Alisa | Director | Aug 10 | Grant / award · A | +75,000 | — | — | 84,557 |
| Markison Brian A | Chief Executive Officer | Aug 08 | Open-market buy · P | +850,000 | $1.55 | +$1.32M | 2,976,020 |
Loading...
